Today: 8 June 2026
Browse Category

Nike 31 December 2025 - 31 May 2026

Nike Stock Ends Winning Run, Bigger Challenge Ahead

Nike Stock Ends Winning Run, Bigger Challenge Ahead

🚨 Nike Stock ALERT! 🚨 Nike just slipped 2.41% to $46.23, hovering dangerously close to its 52-week low—while the rest of Wall Street is hitting all-time highs! The BIGGEST thing investors need to watch right now? **Nike’s June 30th Q4 earnings report.** Why? Because this is the moment management MUST prove their turnaround plan is working, or risk more pain for shareholders. With China sales expected to plunge 20% and competitors like Adidas grabbing market share, Nike’s future—and its stock p
31 May 2026
··
Nike stock climbs but analysts hold back on turnaround calls

Nike stock climbs but analysts hold back on turnaround calls

Nike shares climbed 3.4% to $44.07 Wednesday as falling oil prices and lower U.S. Treasury yields boosted consumer stocks. Nike reported flat quarterly revenue at $11.3 billion, with direct-to-consumer sales down 4% and net income down 35%. The company plans to launch a Google Gemini-powered shopping feature in June. Nike’s global footwear market share slipped to 22.9% in 2025, while Adidas gained, Reuters said.
21 May 2026
··
Nike Stock Gets a Fresh Institutional Signal. The Market Still Looks Split

Nike Stock Gets a Fresh Institutional Signal. The Market Still Looks Split

Nicholas Company disclosed a 123,652-share Nike stake worth $6.53 million as of March 31, even as short interest in Nike rose to 4.67% of shares on loan by May 1. Nike shares traded at $44.14 before Monday’s open, near a 52-week low. Wells Fargo downgraded Nike and cut its price target, citing risks from GLP-1 weight-loss drugs. CEO Elliott Hill and director John Rogers recently bought shares, SEC filings show.
11 May 2026
··
Nike Q3 Earnings Beat Estimates as Turnaround Gains Traction, but China and Tariffs Still Hurt

Nike Q3 Earnings Beat Estimates as Turnaround Gains Traction, but China and Tariffs Still Hurt

Nike reported flat third-quarter revenue at $11.28 billion, beating Wall Street estimates, but net income fell 35% to $520 million. Sales to retail partners rose 5%, offsetting a 4% drop in Nike Direct, while Greater China revenue slid 7%. Gross margin dropped to 40.2% due to higher North America tariffs. CEO Elliott Hill faces continued pressure as the company works to regain investor confidence.
31 March 2026
··
Nike stock slides after-hours as tariff whiplash keeps pressure on NKE

Nike stock slides after-hours as tariff whiplash keeps pressure on NKE

Nike shares fell 3.5% to $63.09 in after-hours trading Monday after President Trump announced a new global tariff plan, reviving trade policy uncertainty. Investors await details on tariff timing and scope, as well as Nike’s next earnings, expected around March 19. Jefferies said Nike could benefit if new tariffs are lower than previous rates. Nike has warned tariff changes could add $1 billion in costs.
24 February 2026
··
Nike stock slips after tariff court shock — what to watch before Monday for NKE

Nike stock slips after tariff court shock — what to watch before Monday for NKE

Nike shares closed Friday down 0.32% at $65.40 after the U.S. Supreme Court struck down Trump’s emergency tariff program. Trump responded by announcing a temporary 15% global import tariff. Investors await details on possible $175 billion in tariff refunds and Nike’s March 19 earnings report. Lululemon and Under Armour rose Friday, while Nike lagged despite a higher S&P 500 and Dow.
21 February 2026
··
Nike stock dips even after Jefferies’ “buy aggressively” call — what NKE investors are watching next

Nike stock dips even after Jefferies’ “buy aggressively” call — what NKE investors are watching next

Nike shares fell 0.6% to $65.52 Monday afternoon, underperforming the broader market despite Jefferies reaffirming its buy rating and $110 price target ahead of the ICR conference. Nike’s latest quarter showed revenue up 1% to $12.4 billion, but net income dropped 32% and gross margin fell to 40.6% due to higher tariffs. Wholesale revenue rose, while direct and Converse sales declined.
12 January 2026
··
Nike stock today: NKE slips after hours as 2026 trading starts — what to watch next

Nike stock today: NKE slips after hours as 2026 trading starts — what to watch next

Nike shares slipped 0.7% to $63.28 on the first trading day of 2026, underperforming rivals as gross margin fell 3 percentage points to 40.6% last quarter. CEO Elliott Hill bought 16,388 shares at $61.10 on Dec. 29, raising his direct stake to 241,587 shares. The stock traded between $62.58 and $64.18 with 22.3 million shares exchanged. Nike reports earnings next on March 19.
3 January 2026
··
Nike stock forecast 2026: CEO’s $1 million buy lifts NKE, but Wall Street targets show a split view

Nike stock forecast 2026: CEO’s $1 million buy lifts NKE, but Wall Street targets show a split view

Nike shares climbed 4% in the last 2025 session after CEO Elliott Hill bought $1 million in stock, SEC filings show. Hill purchased 16,388 shares at an average $61.10 each, while director Tim Cook bought 50,000 shares at $58.97. Nike reported Q2 revenue up 1% to $12.4 billion, but gross margin dropped to 40.6% due to higher North America tariffs. Analyst price targets for 2026 range widely, from $35 to $115.
2 January 2026
··
Nike stock jumps after CEO Elliott Hill’s $1 million buy — what’s next for NKE

Nike stock jumps after CEO Elliott Hill’s $1 million buy — what’s next for NKE

Nike shares closed up 4.1% at $63.71 after CEO Elliott Hill disclosed buying 16,388 shares at a weighted average of $61.10, according to an SEC filing. Hill’s purchase, valued at about $1 million, brought his direct holdings to 241,587 shares. The move came as Nike outperformed a falling market. Investors now await early-January U.S. data and Nike’s next earnings report on March 19.
1 January 2026
··
1 2

Stock Market Today

  • Indian Stock Market July 8: Cautious Start Amid Middle East Tensions
    June 8, 2026, 9:21 AM EDT. Indian stocks are poised for a cautious open on June 8, impacted by rising Middle East tensions and a global market selloff. The GIFT Nifty index fell over 1%, as Asian markets including South Korea and Japan declined sharply, signaling increased investor risk aversion. Higher crude oil prices and a rebound in gold indicate a shift towards defensive assets. Investors will watch key domestic developments in companies like TVS Motor, RailTel, KNR Constructions, Creative Newtech, Amber Enterprises, and Ixigo. Fundraising activities at Zee, ASM Technologies, and Gujarat Themis, along with regulatory issues at Yes Bank, 5Paisa, and Reliance Infrastructure, will also remain in focus.

Latest articles

Plug Power Stock Faces a Make-or-Break Week After Friday’s 10% Drop

Plug Power Stock Faces a Make-or-Break Week After Friday’s 10% Drop

8 June 2026
Plug Power rose 2.95% to $3.31 in Monday pre-market trading after a $39.2 million federal tax credit sale tied to its St. Gabriel hydrogen facility, as investors await CEO Jose Luis Crespo’s June 11 update on liquidity and asset sales amid ongoing losses and a recent 10.69% stock drop.
ABAT Shares Jump on DOE’s $115M Lithium Grant Return

ABAT Shares Jump on DOE’s $115M Lithium Grant Return

8 June 2026
American Battery Technology Co shares soared 29.58% to $4.03 premarket after the U.S. Department of Energy fully reinstated a $115 million grant for its Nevada lithium refinery, restoring federal funding for the Tonopah Flats Lithium Project with no change to awarded funds or milestones, though risks remain from permitting, financing, and volatile lithium prices.
NANO Nuclear Stock Bounces, Investors Eye What’s Next

NANO Nuclear Stock Bounces, Investors Eye What’s Next

8 June 2026
NANO Nuclear Energy jumped 7.8% to $25.40 in premarket trading after a 9.9% Friday drop, as traders weighed fresh insider sales filings and recent regulatory progress on its KRONOS microreactor project; the company held $568.7 million in cash as of March 31, but faces sector-wide volatility and execution risks.
Nurix Shares Jump Premarket on Roche $2.3 Billion Cancer Drug Deal

Nurix Shares Jump Premarket on Roche $2.3 Billion Cancer Drug Deal

8 June 2026
Nurix soared 20.4% to $17.62 premarket after Roche agreed to pay $700 million up front in a bexobrutideg collaboration worth up to $2.3 billion, a major cash boost and external validation for Nurix’s lead blood cancer drug ahead of a planned Phase 3 trial, with Roche’s clinical and commercial backing now in play.
Go toTop